Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 392 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06128993Recruiting
cooling the heart during heart attack treatment
This trial tests a new way to protect the heart during emergency angioplasty by gently cooling the heart with a cold fluid. It may help reduce damage from a heart attack if you are treated within 12 hours.
UxbridgeAges 18 years+ - NCT01372800Recruiting
Study blood adiponectin levels and stroke/heart risk
This study measures a blood marker called adiponectin and looks at how it relates to heart and stroke (cardiovascular and cerebrovascular) problems over time. It may help doctors understand who is at higher risk, especially in Chinese participants.
Xi'an, ShaanxiAges 18–85 - NCT07427199Recruiting
Digital nutrition therapy after heart attack
This study tests whether a digital nutrition program (app- or online-based) can improve heart function after a heart attack. It compares the program to standard care for people who have had a STEMI heart attack.
Samsun, AtakumAges 19–65 - NCT05339477Recruiting
Study of activity after a heart attack
This study follows people after a type 1 heart attack to see how physical activity relates to recovery. It may help doctors understand what activity patterns are best after hospitalization.
AlingsåsAges 18–79 - NCT07388342Recruiting
CT heart scan after cardiac arrest without heart attack
This trial tests whether a special CT scan of the heart can help doctors see blockages in people who survived a cardiac arrest but did not have a typical heart attack. If you qualify, the CT scan might provide important information without needing a standard heart catheterization first.
Brussels, Vlaams BrabantAges 18 years+ - NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT07362446RecruitingPhase 2
Study of a heart drug for first-time heart attack patients
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Kingswood, New South WalesAges 40–75 - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT07345702Recruiting
Endovascular therapy for large core posterior stroke
This trial tests endovascular therapy (a procedure to remove a clot through a tube in an artery) versus medical management for people with a severe stroke due to a blockage in the back part of the brain (basilar artery) and a large area of brain damage. The goal is to see if the procedure improves outcomes compared to medication alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06860646Recruiting
Heart attack study for adults 75 and older
This trial is for older adults aged 75 and up who have had a heart attack. It aims to study the best care for elderly patients with this condition.
RyazanAges 75 years+ - NCT04178434Recruiting
Online therapy for stress and anxiety after heart pain without blockages
This trial studies whether an internet-based therapy program can reduce stress and anxiety in people who may have heart-related conditions like MINOCA or takotsubo syndrome, but without significant coronary artery blockages. If you fit the mood and heart criteria, the program may help you feel calmer and improve day-to-day wellbeing.
StockholmAges 35–79 - NCT05426408Recruiting
Test study for heart attacks without blocked arteries
This study looks at people who may have MINOCA (heart attack symptoms with no major artery blockage) or takotsubo syndrome (a temporary stress-related heart condition). The goal is to better understand these causes and how they should be diagnosed and treated.
StockholmAges 35–79 - NCT07306182RecruitingPhase 2
Testing SGC001 for anterior wall heart attack
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
Shanghai, Shanghai MunicipalityAges 18–79 - NCT07295223RecruitingPhase 3
GLP-1 and SGLT2 drugs for heart attack recovery
This trial tests if combining GLP-1 and SGLT2 medications can reduce inflammation and improve heart function after a heart attack in people with type 2 diabetes and obesity. It looks for patients with a specific type of heart attack, elevated CRP levels, and preserved heart pumping ability.
León, GuanajuatoAges 18 years+ - NCT07293832Recruiting
Beta-blocker therapy for heart attack patients
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Thessaloniki, ThessalonikiAges 18–80 - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT07243769Recruiting
Comparing exercise types for heart rehab
This trial compares core, aerobic, and combined exercise in patients doing phase II cardiac rehab. It aims to find which type works best for heart recovery.
TaipeiAges 18 years+ - NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Shanghai, Shanghai MunicipalityAges 18–100 - NCT07202143RecruitingPhase 3
Steroid treatment for severe stroke with low lymphocyte count
This trial tests if the steroid methylprednisolone helps people who have had a major stroke and also have low infection-fighting white blood cells (lymphocytes). It is for patients who are getting a procedure to remove the clot (thrombectomy) within 24 hours of the stroke.
Fuzhou, FujianAges 18 years+ - NCT07181317Recruiting
Long-term study of young women after heart attack
This study continues to follow young women who had a heart attack to learn more about their long-term health. You can join if you already took part in the earlier WAMIF study.
ParisAges 18–60 - NCT07181356Recruiting
Remote Ischemic Preconditioning for Heart Attack Recovery
This study tests whether a simple, noninvasive procedure called Remote Ischemic Preconditioning (RIPC) — where a blood pressure cuff is briefly tightened on an arm or leg — can improve long-term recovery for people who have had a heart attack. The treatment is done many times over a long period to see if it helps the heart heal and reduces future problems.
Zhengzhou, HenanAges 18 years+ - NCT07139860Recruiting
AI system for early warning after a heart attack
This study tests an artificial intelligence system that watches for early signs of complications after a heart attack. If you join, the system may help doctors catch problems sooner.
BeijingAges 18 years+ - NCT07143136RecruitingEarly Phase 1
Colchicine for heart attack patients with stents
This trial tests if giving colchicine early after a heart attack (when a drug-coated stent is placed) can help reduce complications. It looks at short-term benefits for people with Non-STEMI.
Asyut, Asyut GovernorateAges 18 years+
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 392 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.